Titan Pharmaceuticals (NASDAQ:TTNP) Shares Cross Below Two Hundred Day Moving Average of $7.02

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $7.02 and traded as low as $6.58. Titan Pharmaceuticals shares last traded at $6.82, with a volume of 1,686 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Titan Pharmaceuticals in a research note on Thursday. They set a “sell” rating on the stock.

Titan Pharmaceuticals Price Performance

The stock has a 50 day simple moving average of $7.19 and a two-hundred day simple moving average of $7.02. The company has a market cap of $6.23 million, a price-to-earnings ratio of -0.83 and a beta of 1.32.

About Titan Pharmaceuticals

Titan Pharmaceuticals, Inc, a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder.